Edition:
United States

Mylan NV (MYL.O)

MYL.O on Nasdaq

30.55USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$30.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,055,619
52-wk High
$47.82
52-wk Low
$30.33

Chart for

About

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The... (more)

Overall

Beta: 1.35
Market Cap(Mil.): $20,534.19
Shares Outstanding(Mil.): 536.28
Dividend: --
Yield (%): --

Financials

  MYL.O Industry Sector
P/E (TTM): 31.22 31.13 33.63
EPS (TTM): 1.23 -- --
ROI: 2.39 15.55 15.02
ROE: 5.71 16.92 16.60

Mylan to recall all batches of blood pressure medicine valsartan in U.S.

Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches.

Dec 04 2018

UPDATE 3-Mylan to recall all batches of blood pressure medicine valsartan in U.S.

Dec 4 Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches.

Dec 04 2018

Mylan to recall all batches of blood pressure medicine in U.S.

Dec 4 Mylan NV said on Tuesday it is issuing a nationwide voluntary recall of all lots of its blood pressure medicine valsartan, expanding a recall of select batches initiated two weeks ago.

Dec 04 2018

Teva to recall certain blood pressure medicine in U.S

Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of the medicine.

Nov 27 2018

Teva to recall certain blood pressure medicine in U.S.

Nov 27 Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of the medicine.

Nov 27 2018

Teva prices EpiPen generic at $300, same price as Mylan generic

Teva Pharmaceutical Industries Ltd said on Tuesday it launched its generic version of Mylan NV's EpiPen at the wholesale price of $300 for a pack of two auto-injectors - the same price as Mylan's generic version of the emergency allergy shot.

Nov 27 2018

UPDATE 2-Teva prices EpiPen generic at $300, same price as Mylan generic

Nov 27 Teva Pharmaceutical Industries Ltd said on Tuesday it launched its generic version of Mylan NV's EpiPen at the wholesale price of $300 for a pack of two auto-injectors - the same price as Mylan's generic version of the emergency allergy shot.

Nov 27 2018

Mylan gets FDA warning letter over infractions at West Virginia plant

Mylan NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker's manufacturing plant in West Virginia.

Nov 20 2018

Mylan gets FDA warning letter over infractions at West Virginia plant

Nov 20 Mylan NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker's manufacturing plant in West Virginia.

Nov 20 2018

Mylan recalls batches of blood pressure medicine in U.S.

Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a probable cancer-causing impurity, the latest recall amid heightened safety concerns globally.

Nov 20 2018

Earnings vs. Estimates